ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, vol.27, no.3, pp.121-126, 2018 (ESCI)
Introduction: This study used real-world data to evaluate the effectiveness and reliability of omalizumab in treating recalcitrant chronic spontaneous urticaria in Turkish patients.